Hosted on MSN2mon
Pharmaceutical company to pay $47M for false federal health claims
Sucraid is an FDA-approved therapy for the rare genetic condition Congenital Sucrase-Isomaltase Deficiency (CSID), but it comes with a hefty price tag. QOL and Cooper have admitted that they ...
New IBS Treatment May Be As Effective as Standard Restrictive Diet
This genetic variation—enzymatic sucrase-isomaltase (SI) deficiency—could lead to dietary sugars remaining undigested by the ...
Well+Good6d
Kim Kulp
Learn what sucrase deficiency is along with its causes and types, and discover how to manage it, with tips from a doctor and a dietitian.
Hoodline9d
Massachusetts AG Secures $1.4 Million for MassHealth in $47 Million National Settlement Against QOL Medical Over Kickback Allegations
MassHealth receives $1.4 million from a $47 million settlement with QOL Medical over alleged kickback schemes involving ...